Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2007-5-15
pubmed:abstractText
Severe, sustained pulmonary arterial hypertension leads to a progressive reduction in exercise capacity, right heart failure and death. Use of intravenous epoprostenol has improved survival in adults, but data are limited in children.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17065181-10069788, http://linkedlifedata.com/resource/pubmed/commentcorrection/17065181-10498138, http://linkedlifedata.com/resource/pubmed/commentcorrection/17065181-10520810, http://linkedlifedata.com/resource/pubmed/commentcorrection/17065181-10733441, http://linkedlifedata.com/resource/pubmed/commentcorrection/17065181-11069824, http://linkedlifedata.com/resource/pubmed/commentcorrection/17065181-11157594, http://linkedlifedata.com/resource/pubmed/commentcorrection/17065181-11897647, http://linkedlifedata.com/resource/pubmed/commentcorrection/17065181-12091180, http://linkedlifedata.com/resource/pubmed/commentcorrection/17065181-12093776, http://linkedlifedata.com/resource/pubmed/commentcorrection/17065181-12204511, http://linkedlifedata.com/resource/pubmed/commentcorrection/17065181-12234951, http://linkedlifedata.com/resource/pubmed/commentcorrection/17065181-14533555, http://linkedlifedata.com/resource/pubmed/commentcorrection/17065181-15163595, http://linkedlifedata.com/resource/pubmed/commentcorrection/17065181-15194179, http://linkedlifedata.com/resource/pubmed/commentcorrection/17065181-15194183, http://linkedlifedata.com/resource/pubmed/commentcorrection/17065181-15249494, http://linkedlifedata.com/resource/pubmed/commentcorrection/17065181-15289375, http://linkedlifedata.com/resource/pubmed/commentcorrection/17065181-15358690, http://linkedlifedata.com/resource/pubmed/commentcorrection/17065181-15589643, http://linkedlifedata.com/resource/pubmed/commentcorrection/17065181-16055621, http://linkedlifedata.com/resource/pubmed/commentcorrection/17065181-16278272, http://linkedlifedata.com/resource/pubmed/commentcorrection/17065181-1863023, http://linkedlifedata.com/resource/pubmed/commentcorrection/17065181-4812561, http://linkedlifedata.com/resource/pubmed/commentcorrection/17065181-6301111, http://linkedlifedata.com/resource/pubmed/commentcorrection/17065181-8532025, http://linkedlifedata.com/resource/pubmed/commentcorrection/17065181-9247503, http://linkedlifedata.com/resource/pubmed/commentcorrection/17065181-9813561
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1468-201X
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
93
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
739-43
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed:year
2007
pubmed:articleTitle
Epoprostenol treatment in children with severe pulmonary hypertension.
pubmed:affiliation
Great Ormond Street Hospital for Children and Institute of Child Health, London, UK.
pubmed:publicationType
Journal Article